Boundless Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	96	-	-
Enterprise Value	-8	-119	-62
PB Ratio	-2.24	-	-
EV/EBITDA Ratio	-	2.58	1.43
EV/EBIT Ratio	-	2.41	1.35
EV/FCF Ratio	-	2.51	1.53
Debt / Equity Ratio	-0.01	-0.02	-0.06
Debt / EBITDA Ratio	-	-0.05	-0.12
Debt / FCF Ratio	-	-0.05	-0.13
Quick Ratio	9.91	12.96	8.70
Current Ratio	10.54	13.27	8.80
Return on Equity (ROE)	-	47.40%	-
Return on Assets (ROA)	-	-47.80%	-
Return on Capital (ROIC)	-	43.88%	60.73%
Earnings Yield	-55.54%	-	-
Buyback Yield / Dilution	-10.75%	-
Total Shareholder Return	-10.75%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).